Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03152461 · ClinicalTrials.gov registry record
Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 302
- Enrollment target
NCT03152461: Completed study, sponsored by HemoSonics.
NCT03152461 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 302 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03152461 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 302 participants
- Enrollment target
Study Summary
This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the Quantra Surgical Cartridge in patients undergoing major surgical procedures specifically, major cardiac and vascular procedures and major orthopedic surgery (primarily complex spine surgeries).
Primary Outcome
Coagulation function assessed by Quantra and standard coagulation tests
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2017-05-23 |
| Est. Completion | 2018-02-09 |
What the finished NCT03152461 record still lists
NCT03152461 is an observational study that tracks outcomes without assigning an intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT03152461 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03152461 about?
NCT03152461 is a clinical study titled "Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge". This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the Quantra Surgical Cartridge in patients undergoing major surgical procedures specifically, major cardiac and vascular procedures and major orthopedic surgery (primarily complex spine s...
What is the current status of trial NCT03152461?
This trial is currently completed. The enrollment target is 302 participants. The study started on 2017-05-23. Estimated completion is 2018-02-09.
What interventions are being tested in trial NCT03152461?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03152461?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI